← back to search

Xiaojun Wu

Sichuan University · CN
Area of research
Oncology · Hepatology
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis, and Gastric Cancer Management and Outcomes.
h-index
24
citations
2,478
works
138
NIH funding
primary concept
email

Recent publications

Machine learning-based return-to-work assessment system for acute myocardial infarction patients within 12 months
Heart & Lung 2025cited by 2position: firstdoi
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
PLoS Medicine 2024cited by 17position: middledoi
Effectiveness and Influencing Factors of Home-Center-Based Cardiac Rehabilitation as a Transitional Strategy for Acute Myocardial Infarction Patients
International Heart Journal 2024cited by 2position: middledoi
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer
Autophagy 2023cited by 373position: middledoi
A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance
PLoS Biology 2023cited by 23position: middledoi
Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients
BMC Cancer 2023cited by 20position: middledoi
Activity of Anlotinib in the Second-Line Therapy of Metastatic Gastrointestinal Stromal Tumors: A Prospective, Multicenter, In Vitro Study
The Oncologist 2023cited by 8position: middledoi
Effects of three orthodontic retainers on periodontal pathogens and periodontal parameters
Scientific Reports 2023cited by 5position: middledoi
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
Annals of Surgery 2022cited by 80position: middledoi
Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
Journal of Hematology & Oncology 2021cited by 182position: middledoi
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
Signal Transduction and Targeted Therapy 2021cited by 101position: middledoi
Melatonin synergizes the chemotherapeutic effect of 5‐fluorouracil in colon cancer by suppressing <scp>PI</scp>3K/<scp>AKT</scp> and <scp>NF</scp>‐κB/<scp>iNOS</scp> signaling pathways
Journal of Pineal Research 2016cited by 186position: middledoi
Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer
Oncotarget 2016cited by 94position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhizhong Pan · Sun Yat-sen University3 papers (2021–2023)Wuguo Deng · Guangzhou University of Chinese Medicine2 papers (2016–2023)Xinyu Hou · Ministry of Education of the People's Republic of China2 papers (2024–2025)Xianghui Zheng · Ministry of Education of the People's Republic of China2 papers (2024–2025)Shiyu Wang · Nantong University2 papers (2024–2025)Tianhui Cao · Ministry of Education2 papers (2024–2025)Jianhong Peng · Kunming University of Science and Technology2 papers (2023–2023)Zhenhai Lu · State Key Laboratory of Oncology in South China2 papers (2023–2023)Wendan Yu · Dalian Medical University2 papers (2016–2023)Wei Guo · Dalian Medical University2 papers (2016–2023)Li Li · BGI Group (China)2 papers (2021–2023)Changlin Zhang · Sun Yat-sen University1 papers (2016–2016)Songran Liu · Sun Yat-sen University1 papers (2023–2023)Xiaofeng Sun · The First Affiliated Hospital, Sun Yat-sen University1 papers (2023–2023)Limin Zheng · Weifang University of Science and Technology1 papers (2021–2021)Jiaojiao Hao · Dalian Medical University1 papers (2016–2016)Ling-Heng Kong · Sun Yat-sen University1 papers (2023–2023) · 1 papers (2024–2024)Yujing Fang · Foshan University1 papers (2023–2023)Hongyan Qu · Harbin Medical University1 papers (2023–2023)